fda tirzepatide november 21 says shortage of GLP-1 drug is over Yesterday, the FDA announced approval

Alternative pharmacotherapy may be appropriate for some patients

Modena MG, Bonetti L, Coppi F, Bursi F, Rossi R

Its important to note that current interest in the peptides applications for arthritis remains within the realm of scientific research, and it is not yet approved for clinical use in treating this condition

The combined signaling through both receptors appears to offer a more comprehensive physiological response to nutrient intake than either pathway alone

Editors note: Maria Caranfa is a senior food industry leader driving growth, innovation, and social impact through strategic business integration and communication of nutrition, policy, sustainability, and consumer insights